P1042 : Deregulation of de novo lipogenesis can be associated with liver damage in patients with non alcoholic fatty liver disease
Chiara Rosso(University of Turin), Elisabetta Bugianesi(University of Turin), L. Mezzabotta(University of Turin), Antonina Smedile(Ospedale Papa Giovanni XXIII), Chiara Saponaro(University of Pisa), Maria Lorena Abate(University of Turin), Roberto Gambino(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Federico Salomone, Maurizio Cassader(University of Turin), Amalia Gastaldelli(National Research Council), Francesca Saba(University of Turin), E. Buzzigoli(Istituto di Fisiologia Clinica), E. Vanni, M. Rizzetto(National Institutes of Health), Gian Paolo Caviglia(Department of Medical Sciences), R. Ibrahim Kamal Jouness, Melania Gaggini(Istituto di Fisiologia Clinica)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k